Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher B Yelverton

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Current Problems in Dermatology|July 21, 2007
Exogenous factors in itch responseChristopher B Yelverton, Gil Yosipovitch
Photodermatology, Photoimmunology & Photomedicine|September 5, 2006
The utility of a data-logging device for measuring adherence to home phototherapyChristopher B Yelverton, Rajesh Balkrishnan, Steven R Feldman
Journal of Drugs in Dermatology : JDD|November 24, 2005
Cumulative irritation potential of metronidazole gel compared to azelaic acid gel after repeated applications to healthy skinKristin Ziel, Christopher B Yelverton, Rajesh Balkrishnan, et al.
Managed Care Interface|February 4, 2006
Home ultraviolet B phototherapy: a cost-effective option for severe psoriasisChristopher B Yelverton, Amit S Kulkarni, Rajesh Balkrishnan, et al.
The Journal of Dermatological Treatment|September 14, 2007
Do utilization management controls for phototherapy increase the prescription of biologics?Gregory L Simpson, Christopher B Yelverton, Sheila Rittenberg, et al.
Pediatric Dermatology|September 16, 2008
Use of a silklike bedding fabric in patients with atopic dermatitisEleanor J Kurtz, Christopher B Yelverton, Fabian T Camacho, et al.
The Journal of Dermatological Treatment|January 24, 2006
The rise of the generic drug market and its implications for dermatologyMonali Bhosle, Rajesh Balkrishnan, Tina Dewan, et al.
Journal of Drugs in Dermatology : JDD|August 8, 2007
Managing rosacea: a review of the use of metronidazole alone and in combination with oral antibioticsJennifer F Conde, Christopher B Yelverton, Rajesh Balkrishnan, et al.
Managed Care Interface|August 9, 2006
Would elimination of copayments for phototherapy decrease the cost of treating psoriasis with systemic biologics? A cost analysisJason F Simpson, Christopher B Yelverton, Rajesh Balkrishnan, et al.
Journal of Drugs in Dermatology : JDD|April 1, 2006
Gel vehicles are not inherently more irritating than creamsC Ryan Kirkland, Christopher B Yelverton, Alan B Fleischer, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Current Problems in Dermatology|July 21, 2007
Exogenous factors in itch responseChristopher B Yelverton, Gil Yosipovitch
Photodermatology, Photoimmunology & Photomedicine|September 5, 2006
The utility of a data-logging device for measuring adherence to home phototherapyChristopher B Yelverton, Rajesh Balkrishnan, Steven R Feldman
Journal of Drugs in Dermatology : JDD|November 24, 2005
Cumulative irritation potential of metronidazole gel compared to azelaic acid gel after repeated applications to healthy skinKristin Ziel, Christopher B Yelverton, Rajesh Balkrishnan, et al.
Managed Care Interface|February 4, 2006
Home ultraviolet B phototherapy: a cost-effective option for severe psoriasisChristopher B Yelverton, Amit S Kulkarni, Rajesh Balkrishnan, et al.
The Journal of Dermatological Treatment|September 14, 2007
Do utilization management controls for phototherapy increase the prescription of biologics?Gregory L Simpson, Christopher B Yelverton, Sheila Rittenberg, et al.
Pediatric Dermatology|September 16, 2008
Use of a silklike bedding fabric in patients with atopic dermatitisEleanor J Kurtz, Christopher B Yelverton, Fabian T Camacho, et al.
The Journal of Dermatological Treatment|January 24, 2006
The rise of the generic drug market and its implications for dermatologyMonali Bhosle, Rajesh Balkrishnan, Tina Dewan, et al.
Journal of Drugs in Dermatology : JDD|August 8, 2007
Managing rosacea: a review of the use of metronidazole alone and in combination with oral antibioticsJennifer F Conde, Christopher B Yelverton, Rajesh Balkrishnan, et al.
Managed Care Interface|August 9, 2006
Would elimination of copayments for phototherapy decrease the cost of treating psoriasis with systemic biologics? A cost analysisJason F Simpson, Christopher B Yelverton, Rajesh Balkrishnan, et al.
Journal of Drugs in Dermatology : JDD|April 1, 2006
Gel vehicles are not inherently more irritating than creamsC Ryan Kirkland, Christopher B Yelverton, Alan B Fleischer, et al.
Pageof 2